3 Things Indian Government Should Learn From Singapore: Namita Thapar Shares Video Tips

7/26/2024 3:35:53 PM

(MENAFN- Live Mint) Shark Tank India's prominent investor and Executive director of Emcure Pharmaceuticals Namita Thapar is quite popular on social media for sharing posts related to health and awareness.

Though she mostly shares post giving suggestions to her followers, this time she decided to give three suggestions to the Prime Minister Narendra Modi-led government to learn from Singapore to reduce sugar consumption.

Also Read | 'Shark' Namita Thapar's investment Swells 38,200% After Emcure Pharma Listing

In her latest video, which she posted on Instagram, she asked the Indian government to learn from Singapore to reduce sugar consumption.

First being education in schools related to sugar consumption, guidelines to reduce sugar consumption in drinks and to write labels of sugar amount in drinks. She also pointed that advertisment of these sugar related drinks should also be restricted, so that India can be become diabetic free.

Also Read | Emcure Pharma IPO: Shark Tank's Namita Thapar likely to earn ₹127 cr from OFS

Among other things, she suggested include making children and elders teach to read sugar labels so that they know how much sugar they are consuming.

She wrote, "Pharma with Pharmer ! Episode # 45 (full episode link in bio) teaches how to read food labels esp the sugar content so we can all lead healthier lives. @foodpharmer Revant's honest & bold style is inspiring & a fun watch !"

Here's the Instagram post:

Meanwhile, Namita's Emcure Pharmaceuticals shares made a strong debut on stock market at on July 10 after listing at ₹1,325.05. Emcure's IPO garnered significant investor interest after it ran from July 3-5. It is valued at ₹1,952.03 crores now.

She congratulated the company's staff after it was listed at a 31 per cent price premium.

MENAFN26072024007365015876ID1108487608

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.